107 related articles for article (PubMed ID: 9055722)
1. ABC of clinical haematology. Polycythaemia, primary (essential) thrombocythaemia and myelofibrosis.
Messinezy M; Pearson TC
BMJ; 1997 Feb; 314(7080):587-90. PubMed ID: 9055722
[No Abstract] [Full Text] [Related]
2. The role of alpha-interferon in essential thrombocythaemia, polycythaemia vera and myelofibrosis with myeloid metaplasia (MMM): a concise update.
Sacchi S
Leuk Lymphoma; 1995 Sep; 19(1-2):13-20. PubMed ID: 8574158
[TBL] [Abstract][Full Text] [Related]
3. Thrombocytapheresis and sequential chemotherapy for extreme symptomatic thrombocytosis secondary to myelofibrosis: a case report.
Debureaux PE; Brignier A; Soret-Dulphy J; Réa D; Michonneau D; Peffault de Latour R; Sicre de Fontbrune F; Pagliuca S; Parquet N; Prata HP; Marouf A; Xhaard A; Kiladjian JJ; Socié G; Robin M
Ann Hematol; 2020 Apr; 99(4):897-898. PubMed ID: 32030449
[No Abstract] [Full Text] [Related]
4. The myeloproliferative syndromes.
Penington DG
Med J Aust; 1974 Jul; 2(2):56-64. PubMed ID: 4416373
[No Abstract] [Full Text] [Related]
5. Diagnostic evaluation of the chronic myeloproliferative disorders.
Spivak JL
Isr Med Assoc J; 2002 Nov; 4(11):1028-31. PubMed ID: 12489498
[No Abstract] [Full Text] [Related]
6. Polycythemia and Thrombocytosis.
Parnes A; Ravi A
Prim Care; 2016 Dec; 43(4):589-605. PubMed ID: 27866579
[TBL] [Abstract][Full Text] [Related]
7. [Investigation and management of patients presenting with thrombocytosis].
Cheminant M; Delarue R
Rev Med Interne; 2013 Aug; 34(8):465-71. PubMed ID: 23498669
[TBL] [Abstract][Full Text] [Related]
8. The incidence of myelofibrosis in essential thrombocythaemia, polycythaemia vera and chronic idiopathic myelofibrosis: a retrospective evaluation of sequential bone marrow biopsies.
Kreft A; Büche G; Ghalibafian M; Buhr T; Fischer T; Kirkpatrick CJ
Acta Haematol; 2005; 113(2):137-43. PubMed ID: 15802893
[TBL] [Abstract][Full Text] [Related]
9. [Thrombocytosis].
Nigg C; Naumann UK; Käser L
Praxis (Bern 1994); 2008 Apr; 97(7):343-9; quiz 350-1. PubMed ID: 18548812
[No Abstract] [Full Text] [Related]
10. [Alpha interferon treatment of chronic myeloproliferative disease associated thrombocytosis].
Remes K; Pelliniemi TT
Duodecim; 1993; 109(11):983-9. PubMed ID: 8062671
[No Abstract] [Full Text] [Related]
11. Low incidence of familial occurrence of thrombocythaemia and/or thrombocytosis.
Randi ML; Fabris F; Visentin I; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(5):695-9. PubMed ID: 2465250
[TBL] [Abstract][Full Text] [Related]
12. Post-ET and Post-PV Myelofibrosis: Updates on a Distinct Prognosis from Primary Myelofibrosis.
Passamonti F; Mora B; Barraco D; Maffioli M
Curr Hematol Malig Rep; 2018 Jun; 13(3):173-182. PubMed ID: 29713873
[TBL] [Abstract][Full Text] [Related]
13. Clinico-Pathological Profile And Outcomes Of Patients With Polycythaemia Vera, Essential Thrombocythaemia And Idiopathic Myelofibrosis: A Tertiary Care Center Experience From Southern Pakistan.
Shaikh MS; Shaikh MU; Adil SN; Khurshid M; Ahmed ZA
J Ayub Med Coll Abbottabad; 2016; 28(2):293-297. PubMed ID: 28718562
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of panobinostat, an oral pan-deacetylase inhibitor in patients with primary myelofibrosis, post-essential thrombocythaemia, and post-polycythaemia vera myelofibrosis.
DeAngelo DJ; Mesa RA; Fiskus W; Tefferi A; Paley C; Wadleigh M; Ritchie EK; Snyder DS; Begna K; Ganguly S; Ondovik MS; Rine J; Bhalla KN
Br J Haematol; 2013 Aug; 162(3):326-35. PubMed ID: 23701016
[TBL] [Abstract][Full Text] [Related]
15. A phase I study of panobinostat (LBH589) in patients with primary myelofibrosis (PMF) and post-polycythaemia vera/essential thrombocythaemia myelofibrosis (post-PV/ET MF).
Mascarenhas J; Lu M; Li T; Petersen B; Hochman T; Najfeld V; Goldberg JD; Hoffman R
Br J Haematol; 2013 Apr; 161(1):68-75. PubMed ID: 23330839
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic differentiation of essential thrombocythaemia from thrombocythaemias associated with chronic idiopathic myelofibrosis by discriminate analysis of bone marrow features--a clinicopathological study on 272 patients.
Thiele J; Kvasnicka HM
Histol Histopathol; 2003 Jan; 18(1):93-102. PubMed ID: 12507288
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic emergencies.
Gerson SL; Lazarus HM
Semin Oncol; 1989 Dec; 16(6):532-42. PubMed ID: 2688113
[No Abstract] [Full Text] [Related]
18. Myelofibrosis-polycythemia syndrome on congenital hypoplastic anemia: a case report.
West WO
W V Med J; 1980 Jun; 76(6):134-5. PubMed ID: 6938095
[No Abstract] [Full Text] [Related]
19. [Development of polycythemia to myelofibrosis. Monitoring by the assay of the procollagen III amino-propeptide].
Arrago JP; Poirier O; Najean Y
Presse Med; 1984 Nov; 13(40):2429-32. PubMed ID: 6239221
[TBL] [Abstract][Full Text] [Related]
20. A phase 2 study of simtuzumab in patients with primary, post-polycythaemia vera or post-essential thrombocythaemia myelofibrosis.
Verstovsek S; Savona MR; Mesa RA; Dong H; Maltzman JD; Sharma S; Silverman J; Oh ST; Gotlib J
Br J Haematol; 2017 Mar; 176(6):939-949. PubMed ID: 28220932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
